Clinical Trial Update: RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice

View source ↗

Summary

This document reports a completed post-authorization safety study (RiSPECT) evaluating the safety and effectiveness of risperidone used in routine clinical prac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Schizophrenia, Psychotic Disorders | Status: COMPLETED